-+ 0.00%
-+ 0.00%
-+ 0.00%

IMMUNEERING - ANNOUNCES UPDATED PHASE 2A DATA FOR ATEBIMETINIB IN PANCREATIC CANCER - SEC FILING

Reuters·06/01/2026 20:52:55

Please log in to view news